SEARCH

SEARCH BY CITATION

References

  • Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, Thammavit W. (2006) Lack of association of VDR polymorphism with Thai prostate cancer as compared with benign prostate hyperplasia. Asian Pac J Cancer Prev7:136139.
  • Chen HY, Chen WC, Hsu CD, Tsai FJ, Tsai CH, Li CW. (2001) Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese woman in Taiwan. Osteoporos Int12:10361041.
  • Cooper GS, Umbach DM. (1996) Are vitamin D receptor polymorphisma associated with bone mineral density? A meta-analysis. J Bone Miner Res11:18411849.
  • Creatsa M, Pliatsika P, Kaparos G, Antoniou A, Armeni E, Tsakonas E, Panoulis C, Alexandrou A, Dimitraki E, Christodoulakos G, Lambrinoudaki I. (2011) The effect of vitamin D receptor BsmI genotype on the response to osteoporosis treatment in postmenopausal woman: a pilot study. J Obstet Gynaecol Res37:14151422.
  • Dziak R, Vemillo A, Rifkin B. (1988) The effects of phenytoin on calcium uptake in osteoblastic cells. J Bone Miner Res3:415420.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology58:13481353.
  • Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J. (1997) Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol8:15461552.
  • Garnero P, Munoz F, Borel O, Sornay-Rendu E, Delmas PD. (2005) Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal woman, independently of BMD. J Clin Endocrinol Metab90:48294835.
  • Germaine-Smith C, Liu M, Quan H, Wiebe S, Jelte N. (2011) Development of an epilepsy-specific risk adjustment comorbidity index. Epilepsia52:21612167.
  • Holic MF. (2007) Vitamin D deficiency. N Engl J Med357:226281.
  • Howard G, Nguyen T, Morrison N, Watanabe T, Sambrook P, Eisman J, Kelly PJ. (1995) Genetic influences on bone density: pathological correlates of vitamin D receptor gene alleles in premenopausal woman. J Clin Endocrinol Metab80:28002805.
  • Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT. (2010) Common risk allele in aromatic antiepileptic-drug induced Steven-Johnson syndrome and toxic epidermal necrolysis in Hun Chinese. Pharmacogenomics11:349356.
  • Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD. (2001) Vitamin D receptor polymorphism and the risk of colorectal ademoas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev10:869874.
  • Koide M, Kinugawa S, Ninomiya T, Mizoguchi T, Yamashita T, Maeda K, Yasuda H, Kodayashi Y, Nakamura H, Takahashi N, Udagawa N. (2009) Diphenylhydantoin inhibits osteoclast differentiation and function through suppression of NFATc1 signaling. J Bone Miner Res24:14691480.
  • Kung AW, Yeung SS, Lau KS. (1998) Vitamin D receptor gene polymorphisma and peak bone mass in southern Chinese woman. Bone22:389393.
  • Laaksonen M, Kärkkäinen M, Outila T, Vanninen T, Ray C, Lamberg-Allardt C. (2002) Vitamin D receptor gene BsmI-polymorphism in Finnish premenopausal and postmenopausal woman: its association with bone mineral density, markers of bone turnover, and intestinal calcium absorption, with adjustment for lifestyle factors. J Bone Miner Metab20:383390.
  • Lado F, Spiegel R, Masur JH, Boro A, Haut SR. (2008) Value of routine screening for bone demineralization in an urban population of patients with epilepsy. Epilepsy Res78:155160.
  • Lambrinoudaki I, Kaparos G, Armeni E, Alexandrou A, Damaskos C, Logotheis E, Creatsa E, Antoniou A, Kouskouni E, Triantafyllou N. (2011) Bsml vitamin D receptor’s polymorphism and bone mineral density in men and premenopausal woman on long term antiepileptic therapy. Eur J Neurol18:9398.
  • Langdahl BL, Gravholt CH, Brixen K, Kriksen EF. (2000) Polymorphisms in the vitamin D receptor gene and bone mass, bone turnover and osteoporotic fracture. Eur J Clin Invest30:608617.
    Direct Link:
  • Lau KH, Nakade O, Barr B, Taylor AK, Houchin K, Baylink DJ. (1995) Phenytoin increases marker of osteogenesis for the human species in vitro and vivo. J Clin Endocrinol80:23472353.
  • Löscher W, Klotz U, Zimprich F, Schmidt D. (2009) The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia50:123.
  • Mamiya K, Leiri I, Shimamoto J, Yukawa E, Imai J, Ninomiya H, Yamada H, Otsubo K, Higuchi S, Tashiro N. (1998) The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics. Epilepsia39:13171323.
  • Morrison NA, Yeoman R, Kelly PJ, Eisman JA. (1992) Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A89:66656669.
  • Morrison NA, QI JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. (1994) Prediction of bone density from vitamin D receptor alleles. Nature367:284287.
  • Pack AM, Olarte LS, Morrell MJ, Flaster E, Resor SR, Shane E. (2003) Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav4:169174.
  • Petty SJ, O’Brien TJ, Wark JD. (2007) Anti-epileptic medication and bone health. Osteoporos Int18:129142.
  • Phabphal K, Geater A, Leelawattana R, Sathirapanya P, Sattawacharawanich S, Limapichat K. (2009) Prevalence and risk factors of low bone mineral density and 25-hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug. Bone45:232237.
  • Saiz J, Van Tomout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. (1997) Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med337:7782.
  • Tagliabue J, Farina M, Imbasciati E, Vergani C, Annoni G. (1999) BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients. Am J Clin Pathol112:366370.
  • Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Shigematsu Y, Tsukahara Y, Miura M, Mayumi M. (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int44:247253.
  • Valdivielso JM, Fernandez E. (2006) Vitamin D receptor polymorphisms and diseases. Clin Chim Acta37:112.
  • World Health Organization, International Association for the Study of Obesity, International Obesity Task Force. (2000) The Asia-Pacific perspective: redefining obesity and its treatment. Sydney Health Communications, Geneva.